Featured post
Introducing our new portfolio review service for professionals
The vast majority of pensions funds, charities, endowments and other institutional portfolios have underperformed the market for decades. The way to stop the rot is to have an independent portfolio review, reduce fees and complexity, and increase diversification. From today, that’s precisely what TEBI is offering. As anyone who’s read The...
Ten market predictions to count on in 2021
Anyone familiar with The Evidence-Based Investor will know we’re highly sceptical about the value of financial market forecasts. And if the events of 2020 didn’t convince you of that point, nothing will. But every now and then, even we are willing to...
The most over- and under-hyped benefits of ETFs
By BEN JOHNSON As an investment wrapper, exchange-traded funds have several beneficial characteristics. But I would argue that some have been oversold — made out to be more significant than they are. Others have been undersold — not given their due. In both cases, I...
Coming soon — a Darwinian cull of active management
By MARK NORTHWAY from Sparrows Capital It is always hard to know what will happen with markets. My colleagues and I at Sparrows are not in the business of offering predictions. Instead, like some of the successful sovereign and endowment funds...
Transparency is good for business for asset managers
By JOACHIM KLEMENT Fund managers around the world are increasingly facing new regulations that will require them to disclose more information on the climate-related risks of their investments, as well as their fees and charges. Talking to both fund managers and...
Social trading platforms are bad for your wealth
By LARRY SWEDROE As evidenced by the dramatic growth of Robinhood, many investors are now getting their investment ideas from others on the internet. Manuel Ammann and Nic Schaub, authors of the June 2020 study Do Individual Investors Trade on Investment-related...
The value of a second opinion
The classic 2002 book When Genius Failed tells the true story of a hedge fund, run by a supremely confident Wall Street bond dealer. With the help of two Nobel laureate economists, he thought he had cracked the code to make...